Pliant Therapeutics Inc. (PLRX) Live Share Price, Invest From India

Pliant Therapeutics Inc. Stock Performance

as on July 3, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.11
Day's Price Range
$1.18
$1.17
5.13%
Downside
0.85%
Upside
52 Week's Low
52 Week's High
$1.09
52-Week Price Range
$1.95
$1.17
6.84%
Downside
66.67%
Upside

Pliant Therapeutics Inc. share price movements today

Previous Close: $1.11
Open: $1.11
Volume: 860.8K
Day's Low - High: $1.11 - $1.18
52 Week Low - High: $1.09 - $1.95

Pliant Therapeutics Inc. Historical Returns

1 Month Return: -0.85 %
3 Month Return: -13.33 %
1 Year Return: -7.14 %
3 Year Return: -93.5 %
5 Year Return: -95.84 %

Pliant Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Pliant Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$68.7M

EPS (TTM)

-1.4097

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-111.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-53.62%

Pliant Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pliant Therapeutics Inc.	BUY	$68.7M	-95.84%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.9B	478.19%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$40.3B	82.45%	75.8	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.4B	163.31%	29.59	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.5B	12.1%	15.25	29.65%	0.5700000000000001%

Stock Returns calculator for Pliant Therapeutics Inc. Stock including INR - Dollar returns

The Pliant Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Pliant Therapeutics Inc. investment value today

Current value as on today

₹1,03,474

Returns

₹3,474

(+3.47%)

Returns from Pliant Therapeutics Inc. Stock

-₹7,143 (-7.14%)

Dollar Impact

₹10,616 (+10.62%)

Analyst Recommendation on Pliant Therapeutics Inc. Stock

Based on 20 analysts

BUY

95.00%

Buy

5.00%

Hold

0.00%

Sell

Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Pliant Therapeutics Inc.. Average target price of $2.5

Pliant Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Pliant Therapeutics Inc..

What analysts predicted

53.2%UPSIDE

Target Price

$2.5

Current Price

$1.17

Analyzed by

20 Analysts

Target

$2.50

Pliant Therapeutics Inc. target price $2.5, a slight upside of 53.2% compared to current price of $1.17. According to 20 analysts rating.

Indian Investors' Interest in Pliant Therapeutics Inc. Stock

Search interest for Pliant Therapeutics Inc. Stock has increased by 163% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 4, 2026 to July 4, 2026

Change:163% versus previous 30 day period

Pliant Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	4	-	-	-	2	-	-	-	-	-
Gross Profit	4	0	0	0	1	0	0	-	0	0
Operating Income	-47	-52	-60	-62	-53	-58	-45	-28	-23	-21
EBITDA	-40	-45	-54	-56	-48	-54	-42	-23	-23	-19
Interest Expense	0	0	0	0	0	0	0	0	0	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-41	-46	-55	-57	-49	-56	-43	-26	-23	-20
Income Tax Expense	3	0	-	-	-	-	-	-	-	-
Net Income	-41	-46	-55	-57	-49	-56	-43	-26	-23	-20
Net Profit Margin	-849.36%	0.00%	0.00%	0.00%	-2190.84%	0.00%	0.00%	0.00%	0.00%	0.00%

Pliant Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	57	41	7	9	1	-	-
Gross Profit	0	57	41	7	9	1	-2	-1
Operating Income	-30	-1	-41	-19	-127	-184	-228	-150
EBITDA	-30	0	-40	-18	-118	-158	-205	-145
Interest Expense	-	0	0	0	0	1	3	2
Depreciation	0	1	1	1	1	1	2	1
Income Before Tax	-30	0	-41	-19	-123	-161	-210	-149
Income Tax Expense	0	0	-1	-1	-1	1	-	-
Net Income	-30	0	-39	-17	-123	-161	-210	-149
Net Profit Margin	0.00%	-1.11%	-95.05%	-236.49%	-1273.32%	-10211.14%	0.00%	0.00%

Pliant Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-46	-55	-57	-49	-56	-43	-26	-23	-20
Operating Cash Flow	-30	-45	-32	-47	-48	-40	-21	-17	-19
Investing Cash Flow	59	10	30	39	69	35	27	1	-4
Financing Cash Flow	21	0	0	0	0	-	0	-32	0
Change in Cash	51	-33	0	-8	20	-5	6	-48	-23

Pliant Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-30	0	-41	-97	-123	-161	-210	-149
Operating Cash Flow	-28	-2	-37	-75	-94	-116	-155	-128
Investing Cash Flow	-2	-17	-210	73	-150	-127	140	134
Financing Cash Flow	87	45	213	2	226	274	23	-31
Change in Cash	56	24	-34	0	-17	31	7	-25

Global Institutional Holdings in Pliant Therapeutics Inc.

Funds	Holdings
Deep Track Capital, LP	6.43%
TANG CAPITAL MANAGEMENT LLC	9.92%
ADAR1 Capital Management LLC	4.17%
Great Point Partners LLC	1.38%
BML Capital Management LLC	2.5%

See all

Insights on Pliant Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -56.16M → -20.04M (in $), with an average increase of 30.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.7% return, outperforming this stock by 406.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 605.3% return, outperforming this stock by 698.8%
NEGATIVE IMPACT
Price Dip
In the last 3 years, PLRX stock has moved down by -93.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter

About Pliant Therapeutics Inc.

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Organisation	Pliant Therapeutics Inc.
Headquarters	331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Dr. Bernard Coulie M.B.A., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Pliant Therapeutics Inc.

Name	Title
Mr. Christopher S. Keenan	Vice President of Investor Relations & Corporate Communications
Monica Sandberg Ph.D.	Vice President, Regulatory & Compliance
Ms. Lily Cheung	Chief Human Resources Officer
Dr. Keith Lamont Cummings M.B.A., M.D.	Chief Financial Officer
Dr. Rik Derynck Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. Dean Sheppard M.D.	Scientific Founder & Member of Scientific Advisory Board
Ms. Delphine Imbert Ph.D.	Chief Technical Officer
Dr. Bernard Coulie M.B.A., M.D., Ph.D.	President, CEO & Director
Ms. Minnie Kuo	Chief Operating Officer
Mr. Hal Chapman M.D.	Scientific Founder & Member of Scientific Advisory Board

FAQs

What is Pliant Therapeutics Inc. share price today?

Pliant Therapeutics Inc. share price today is $1.17 as on July 3, 2026 at 8:46 am IST at the close of the market. Pliant Therapeutics Inc. share today touched a day high of $1.18 and a low of $1.11.

What is the 52 week high and 52 week low for Pliant Therapeutics Inc. share?

Pliant Therapeutics Inc. share touched a 52 week high of $1.95 on October 27, 2025 and a 52 week low of $1.09 on February 5, 2026. Pliant Therapeutics Inc. stock price today i.e. July 3, 2026 at 8:46 am IST is closed at $1.17,which is 40.00% down from its 52 week high and 7.34% up from its 52 week low.

What is Pliant Therapeutics Inc.'s market capitalisation today?

Pliant Therapeutics Inc. market capitalisation is $0.00T as on July 3, 2026 at 8:46 am IST.

How to invest in Pliant Therapeutics Inc. Stock (PLRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pliant Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pliant Therapeutics Inc. Shares that will get you 1.2821 shares as per Pliant Therapeutics Inc. share price of $1.17 per share as on July 3, 2026 at 8:46 am IST.

What is the minimum amount required to buy Pliant Therapeutics Inc. Stock (PLRX) from India?

Indian investors can start investing in Pliant Therapeutics Inc. (PLRX) shares with as little as ₹95.2 or $1 (as of July 4, 2026 at 5:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Pliant Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 4, 2026 at 5:38 am IST). Based on Pliant Therapeutics Inc. share’s latest price of $1.17 as on July 3, 2026 at 8:46 am IST, you will get 8.5470 shares of Pliant Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Pliant Therapeutics Inc. has given to Indian investors in the last 5 years?

Pliant Therapeutics Inc. stock has given -95.84% share price returns and 27.38% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?